Personalis at Neoantigen Summit Europe: APR 24-26, 2018
Presentation
Sean Michael Boyle, PhD
Director, Bioinformatics Applications
Personalis, Inc.
From Sample to Neoantigens for Vaccines:
Key Challenges and Solutions
Points that will be covered in his presentation:
- cfDNA neoantigens: dealing with tumor heterogeneity
- Improving neoantigen identification
- Elaborating TME, immuno-modulators and vaccine response biomarkers
- Overcoming poor sample quality and quantity for NGS sequencing
- Overcoming sequencing gaps that can harbor neoantigens
- Validation and regulatory issues on the way to commercialization